Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1

Interventions

Therapeutics 4Exercise 2Early Intervention, Educational 2Acceptance and Commitment Therapy 2clazakizumab 1Yoga 1Vinorelbine 1Uncertainty 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Radiotherapy 1Qigong 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Physical Therapy Modalities 1Modafinil 1Minocycline 1Infliximab 1Gemcitabine 1Fluoxetine 1Escitalopram 1Educational Status 1Docetaxel 1Cognitive Behavioral Therapy 1Cisplatin 1Caregivers 1Carboplatin 1Behavior Therapy 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Escitalopram × Thoracic × Clear all
NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Massachusetts General Hospital

Phase 3 Terminated
24 enrolled 11 charts
GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡